共 181 条
- [1] Forner A(2012)Hepatocellular carcinoma Lancet 379 1245-1255
- [2] Llovet JM(2015)Management of hepatocellular carcinoma with portal vein thrombosis World J Gastroenterol 21 3462-3471
- [3] Bruix J(2006)Treatment of hepatocellular carcinoma accompanied by portal vein tumor thrombus World J Gastroenterol 12 7561-7567
- [4] Quirk M(2014)Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus Surg Today 44 219-226
- [5] Kim YH(2020)Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO MOS and SSO Ann Oncol 31 334-351
- [6] Saab S(2018)EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma J Hepatol 69 182-236
- [7] Lee EW(2022)Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus Ann Hepatol 27 100552-634
- [8] Minagawa M(2011)Transarterial chemoembolization can be safely performed in patients with hepatocellular carcinoma invading the main portal vein and may improve the overall survival Radiology 258 627-180
- [9] Makuuchi M(2015)Doxorubicin-loaded drugeluting beads versus conventional transarterial chemoembolization for nonresectable hepatocellular carcinoma Saudi J Gastroenterol 21 175-504
- [10] Katagiri S(2015)Transarterial chemoembolization with doxorubicin-eluting particles versus conventional transarterial chemoembolization in unresectable hepatocellular carcinoma: a study of effectiveness, safety and costs Radiologia 57 496-1867